Imaging in endometrial carcinoma has many roles. It is used in the initial assessment of symptomatic patients for demonstration of abnormal endometrial thickness. Once the histological diagnosis of endometrial carcinoma is confirmed, imaging can accurately stage the tumour, facilitating surgical and oncological treatment planning. This article will review the different imaging techniques available and their roles in staging, treatment selection and follow-up of patients with endometrial carcinoma.
Determination of the depth of myometrial invasion is important, since it correlates with the incidence of lymph node metastases. Pre-operative evaluation of prognostic factors helps in sub-specialist treatment planning. Although endometrial carcinomas are typically diagnosed at endometrial biopsy, imaging fulfils an important role in both the assessment and staging of these patients.
Role of Ultrasound
The main role of transvaginal ultrasound (TVS) is the accurate assessment of endometrial thickness in patients presenting with postmenopausal bleeding. Ultrasound is widely available, does not involve the use of ionising radiation and has a high negative predictive value, facilitating the assessment of post-menopausal patients into high-and low-risk groups. Ultrasound has a high sensitivity in assessing whether the endometrium is abnormal but a low specificity because benign conditions can also cause a thickened endometrium.
2 Usually, a normal post-menopausal endometrium is atrophic, measuring less than 5mm in thickness and appearing as a thin echogenic line. Endometrial thickness must be assessed on TVS by measuring the two opposing endometrial layers in the sagittal plane, excluding endometrial fluid in the measurement. Endometrial cancer appears as non-specific thickening of the endometrium that is difficult to distinguish from hyperplasia or a polyp, unless myometrial invasion is present. 
Role of Magnetic Resonance Imaging
Endometrial carcinomas are typically diagnosed at endometrial biopsy 
Role of Computed Tomography
CT with both intravenous and oral contrast medium may be used to stage endometrial carcinoma when MRI is contraindicated. Endometrial tumours appear as low-attenuation lesions relative to a normally enhancing myometrium. CT has limited value in the accurate assessment of myometrial invasion due to its low contrast resolution and hence the inability to visualise the JZ. CT is most useful in confirming the presence of enlarged lymph nodes, which indicate stage III disease.
There is a tendency to understage bladder and bowel involvement.
Cervical extension is difficult to evaluate as the cervix is poorly delineated on CT. There is a reported sensitivity of 83% and specificity of 42% for the detection of stage IC disease and a sensitivity of 25% and The Role of Imaging in Advanced Endometrial Carcinoma 
Role of Imaging in Treatment Follow-up of Endometrial Carcinoma
The vagina is the sole site of recurrence in 30-50% of patients with endometrial carcinoma. The remainder develop pelvic or para-aortic lymph node involvement or systemic spread, manifesting as hepatic, pulmonary or osseous metastasis, or peritoneal carcinomatosis. 
Magnetic Resonance Imaging

Computed Tomography
CT examination is excellent in the follow-up of distant metastatic disease and nodal disease. The volume of metastatic pulmonary nodules or liver or bony metastatic disease can be accurately assessed by CT following the administration of both intravenous and oral contrast medium. In the future, the sensitivity of disease recurrence in imaging follow-up may be increased by the use of combined PET/CT examination.
Conclusion
The recommended imaging algorithm for endometrial cancer is TVS as 
